Latest Options News

Southern Palladium fast-tracks development at its Bengwenyama PGM Project, advancing drilling and infrastructure plans while securing key regulatory approvals.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for PYC-003, an RNA therapy targeting Polycystic Kidney Disease. This milestone moves the drug closer to pivotal Phase 2/3 trials.

Basin Energy has agreed to sell its Marshall Uranium Project to Green Canada Corporation, securing cash, shares, and a significant equity stake while retaining strategic rights and exposure to Canadian uranium assets.

WAM Income Maximiser Limited has confirmed its fully franked ordinary dividend for November 2025 and updated the Dividend Reinvestment Plan price, providing clarity for investors ahead of the payment date.

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.

Critica Limited has completed the first tranche of its $8 million placement, issuing over 203 million shares to accelerate development at its Jupiter rare earths project. The second tranche awaits shareholder approval in January 2026.

Mt Malcolm Mine NL has supplemented its October Rights Issue with a $750,000 Placement Offer, updating its capital structure and funding plans to accelerate exploration and repay director loans.

Aurumin Limited’s acquisition by Brightstar Resources has been legally approved, triggering a share exchange and imminent delisting from the ASX.

Cobalt Blue Holdings has significantly upgraded the economics of its Kwinana Cobalt Refinery project, driven by a sharp rebound in cobalt prices following market disruptions in the Democratic Republic of Congo. The company is advancing towards a Final Investment Decision with key permits and supply agreements in place.

Lifestyle Communities Limited reported a challenging FY25 marked by a significant $135.5 million after-tax write-down following a VCAT ruling, while signaling early signs of recovery and strategic reset for FY26.

Anson Resources has raised A$14 million through a well-supported placement to advance its lithium and uranium projects in Utah, signaling strong investor confidence in its development strategy.

Lodestar Minerals has responded to ASX queries clarifying the timing and disclosure of key assay results from its Ned’s Creek gold project and detailed the procedural steps behind its Arizona Mountain Pass rare earths acquisition.